Medications Updated During December 2019, From Oldest to Newest, Page 2

Page 2 of 135 « 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Promethazine with Codeine (Promethazine Hydrochloride and Codeine Phosphate)

Promethazine with codeine syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. CONTRAINDICATIONS: The…

Proficient Rx LP1 December 2019

Esomeprazole Magnesium

Esomeprazole magnesium delayed-release capsule USP is a proton pump inhibitor indicated for the following: 5. Treatment of gastroesophageal reflux disease (GERD) (1.1) 6. Risk reduction…

Proficient Rx LP1 December 2019

Methadone Hydrocloride (Methadone Hydrochloride)

For detoxification treatment of opioid addiction (heroin or other morphine-like drugs). For maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction…

Lannett Company, Inc.1 December 2019

Famotidine

Famotidine tablets are indicated in adult and pediatric patients 40 kg and above for the treatment of: active duodenal ulcer. active gastric ulcer. symptomatic non-erosive…

Golden State Medical Supply, Inc.2 December 2019

Calcium Acetate

Calcium Acetate Capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). Calcium Acetate Capsules are a phosphate binder…

Golden State Medical Supply, Inc.2 December 2019

Page 2 of 135 « 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and lot EG8933 of 1% Lidocaine HCl Injection, USP 30 mL, to the hospital/institution level due to mislabeling whereby a…
Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot DN9185 of Sterile Water for Injection, USP, 100 mL Single Dose Glass Fliptop Vial, to the hospital/institution level due to a confirmed customer report for a single vial with a visible…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.